Innovhem’s patents have been issued !

by Innovhem | November 8, 2024

Cette actualité appartient aux catégories suivantes : Uncategorized

Innovhem’s patents protect our BIOMARKERS : An important news !
SINGLE CELL QUANTIFICATION OF FETAL HEMOGLOBIN patent has been issued in France, Nigeria and in the US.
And our 2 patents cover INTRAVASCULAR HEMOLYSIS ASSAY in Europe and in the US.
Stay tuned for future important milestones!

Lastest news of Innovhem

Measure HbF at the Single-Cell Level: Prof. Martin Steinberg’s ASH 2025 Insight

December 23, 2025

Measure HbF at the single-cell level is no longer optional—it is essential for advancing sickle cell disease care. First, at #ASH2025, Prof. Martin...

Marie Cambot Awarded Chevalier de l’Ordre National du Mérite

October 23, 2025

Paris, France – October 14, 2025 – Innovhem announces its co-founder and CEO Marie Cambot has been awarded Chevalier de l’Ordre National du Mérite....

New publication !

September 11, 2025

Innovhem proudly shares its latest scientific publication in Haematologica Journal, highlighting our commitment to advancing hematology research. In...

Aventure France 2030 !

April 11, 2025

Aventure France 2030 ! 🏆 Hier, à Paris, se tenait le Comité interministériel de l'innovation C2i. Nous sommes fiers de faire partie de...

🚨 Another step forward in the fight against sickle cell disease !

April 8, 2025

Another step forward in the fight against sickle cell disease ! On the occasion of the state visit to France by Their Majesties King Frederik X and...

Innovhem will present new data at the 2024 ASH Annual Meeting

November 15, 2024

Innovhem to present New data on single-cell quantification of HbF and HbS at the 2024 ASH Annual Meeting. One poster presentation to feature new...